The pharmaceutical industry worldwide is a rapidly burgeoning industry contributing to growth of gross domestic product and employment. Technological change in this field has been very rapid, with many new products being introduced. For this reason in part, health care budgets throughout the world h
Pharmaceutical Innovation: Incentives, Competition, and Cost-Benefit Analysis in International Perspective
β Scribed by Frank A. Sloan, Chee-Ruey Hsieh
- Publisher
- Cambridge University Press
- Year
- 2007
- Tongue
- English
- Leaves
- 349
- Edition
- 1
- Category
- Library
No coin nor oath required. For personal study only.
β¦ Synopsis
The pharmaceutical industry worldwide is a rapidly burgeoning industry contributing to growth of gross domestic product and employment. Technological change in this field has been very rapid, with many new products being introduced. For this reason in part, health care budgets throughout the world have increased dramatically, eliciting growing pressures for cost containment. This book explores four important issues in pharmaceutical innovations: (1) the industry structure of pharmaceutical innovation; (2) incentives for correcting market failures in allocating resources for research and development; (3) competition and marketing; and (4) public evaluation of the benefits and costs of innovation. The lessons are applicable to countries all over the world, at all levels of economic development. By discussing existing evidence this book proposes incentive arrangements to accomplish social objectives
π SIMILAR VOLUMES
<p>This book is open access under a CC BY 4.0 license.<br><br>This book investigates what international placements of healthcare employees in low resource settings add to the UK workforce and the efficacy of its national health system. The authors present empirical data collected from a volunteer de
For undergraduate courses in cost-benefit analysis. A practical introduction to cost-benefit analysis through problem solving. This authoritative, market-leading text is known for its consistent application of a nine-step framework for conducting or interpreting a cost-benefit analysis. This edition
<p><p>Incentives for innovation are particularly relevant in the pharmaceutical</p><p>industry where not all social needs provide equally profitable</p><p>opportunities and where most OECD countries try to implement diffe -</p><p>rent measures that promote research in these less profitable areas. Th